96 related articles for article (PubMed ID: 2805953)
1. [Therapeutic effect of defibrase in chronic glomerulonephritis with chronic renal failure].
Wu JF; Wang SH
Zhonghua Nei Ke Za Zhi; 1989 Mar; 28(3):171-3, 188. PubMed ID: 2805953
[TBL] [Abstract][Full Text] [Related]
2. [Clinical efficacy and safety of sequential treatment with alprostadil and beraprost sodium for chronic renal failure induced by chronic glomerulonephritis].
Chen Y; Wan JX; Jiang DW; Fu BB; Cui J; Li GF
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1521-4. PubMed ID: 24144760
[TBL] [Abstract][Full Text] [Related]
3. [Effect of plasma fibrinogen level-based defibrase therapy in patients with acute cerebral infarction].
Cai XB; Zhu ZS; Zhang MZ; Guo J; Wang HL
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2124-7. PubMed ID: 19861283
[TBL] [Abstract][Full Text] [Related]
4. [The ability of partusisten to improve kidney excretory function in the initial stage of kidney failure in patients with chronic glomerulonephritis].
Skipskiĭ IM; Komandenko MS; Shulutko BI; Zamoskovskaia GA
Ter Arkh; 1991; 63(12):125-7. PubMed ID: 1803590
[TBL] [Abstract][Full Text] [Related]
5. Renal vein fibrin degradation products (FDP's) in glomerulonephritis.
Tomura S; Ideura T; Ida T; Osaka Y; Kuriyama R; Abe T; Takeuchi J
Clin Nephrol; 1979 Dec; 12(6):248-53. PubMed ID: 527278
[TBL] [Abstract][Full Text] [Related]
6. [Features of a cytokine profile in patients with chronic glomerulonephritis with progressive chronic renal failure].
Koriakova NN; Rozhdestvenskaia ED; Kazantseva SV; Bushueva TV; Valamina IE
Ter Arkh; 2006; 78(5):14-7. PubMed ID: 16889043
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum and urinary neopterins in patients with chronic renal disease.
Godai K; Uemasu J; Kawasaki H
Clin Nephrol; 1991 Sep; 36(3):141-6. PubMed ID: 1934670
[TBL] [Abstract][Full Text] [Related]
8. [Experience in the use of valsartan with the aim to inhibit progression of kidney failure in patients with chronic glomerulonephritis].
Shvetsov MIu; Medvedeva TIu; Kozlovskaia NL; Miroshnichenko NG; Okonova EB; Shonichev DG; Rudenko TE; Stavrovskaia EV; Plieva OK
Ter Arkh; 2001; 73(6):55-61. PubMed ID: 11521525
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of nitric oxide levels in patients with chronic glomerulonephritis].
Barbarash OL; Pavlova VIu; Chesnokova IuL; Bazdyrev ED; Malyshev IIu; Manukhina EB
Klin Med (Mosk); 2007; 85(5):57-61. PubMed ID: 17665607
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of defibrase in treatment of acute cerebral infarction.
Guo Y; Zuo YF; Wang QZ; Tang BS; Li FK; Sun Y
Chin Med J (Engl); 2006 Apr; 119(8):662-8. PubMed ID: 16635411
[TBL] [Abstract][Full Text] [Related]
11. [The effect of the angiotensin-converting enzyme inhibitor enalapril on the rates of progression of chronic kidney failure in patients with different degrees of functional kidney disorders].
Esaian AM; Kaiukov IG; Titova VA
Ter Arkh; 1995; 67(6):57-9. PubMed ID: 7667785
[TBL] [Abstract][Full Text] [Related]
12. Effect of combined treatment of oral sorbent with protein-restricted diet on change of reciprocal creatinine slope in patients with CRF.
Sanaka T; Fujimoto K; Niwayama J; Nishimura H; Naito T; Higuchi C; Akizawa T; Koide K; Koshikawa S
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S35-7. PubMed ID: 12612949
[TBL] [Abstract][Full Text] [Related]
13. [The effect of blood pressure control on the progression of chronic glomerulonephritis associated with hypertension].
Arima S; Abe K; Kudo K; Tsunoda K; Yabe T; Imai Y; Saito T; Sato H; Yoshinaga K
Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):597-604. PubMed ID: 1920940
[TBL] [Abstract][Full Text] [Related]
14. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP
Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
[TBL] [Abstract][Full Text] [Related]
15. [Effect of protein load on kidney functions in patients with chronic glomerulonephritis].
Esaian AM; Kucher AG; Kaiukov IG; Ermakov IuA; Nikogosian IuA; Riabov SI
Ter Arkh; 2002; 74(6):19-24. PubMed ID: 12136476
[TBL] [Abstract][Full Text] [Related]
16. [Changes in the filtration function of the kidneys during the treatment of chronic glomerulonephritis].
Riabov SI; Stavskaia VV; Kozlov VV; Kucher AG
Ter Arkh; 1994; 66(8):52-7. PubMed ID: 7985156
[TBL] [Abstract][Full Text] [Related]
17. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
[TBL] [Abstract][Full Text] [Related]
18. [Study on coagulation fibrinolytic systems in predialysis patients with chronic renal failure--comparison between patients with chronic glomerulonephritis and patients with diabetic nephropathy].
Nagake Y; Makino H; Yorioka N; Nomura S; Osawa G; Yamakido M; Kawasaki H; Kato Y; Matsuzaki M; Shikata K; Uemasu J; Somiya H; Fujii Z; Hayashida S; Nasu T; Oyabu Y; Nitta Y; Kawanishi H; Usui K; Fujiwara K; Takasugi N; Kanehara K; Hamaguchi N; Kumagai I; Ota Z
Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):474-82. PubMed ID: 9283213
[TBL] [Abstract][Full Text] [Related]
19. [Effect of protease inhibitor on primary glomerulonephritis and the mechanism of the effect].
Onbe T; Makino H; Haramoto T; Wada J; Ogura T; Kumagai I; Murakami K; Fukushima M; Ota Z
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):753-9. PubMed ID: 1770635
[TBL] [Abstract][Full Text] [Related]
20. [Clinical effects of trandolapril in chronic glomerulonephritis patients with renal insufficiency].
Yoshida A; Takeda A; Fukuda M; Toda S; Morozumi K
Nihon Jinzo Gakkai Shi; 2000 May; 42(4):333-7. PubMed ID: 10897592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
